Clinical trial
Fecal Microbiota Transplant for Inflammatory Bowel Disease
NCT02460705 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT02460705 |
|---|---|
| Title | Fecal Microbiota Transplant for Inflammatory Bowel Disease |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease |
| Intervention type | Drug |
| Interventions | Biologically active human fecal material, OpenBiome |
| Enrollment | 59 |
| Start date | Jun 1, 2015 |
| Primary completion | Dec 20, 2016 |
| Completion | Nov 4, 2017 |
| First posted | Jun 2, 2015 |
| Last update posted | Jun 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: